Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer

Gelijkaardige items

• The Application of Real-Time PCR Technique to Detect Rare Cell Clones with Primary T790M Substitution of EGFR Gene in Metastases of Non-small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients
  door: Powrózek, Tomasz, et al.
  Gepubliceerd in: (2014)
• Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
  door: Krawczyk, Paweł, et al.
  Gepubliceerd in: (2015)
• Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
  door: Nicoś, Marcin, et al.
  Gepubliceerd in: (2019)
• The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
  door: Krawczyk, Paweł, et al.
  Gepubliceerd in: (2013)
• Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer
  door: Szczyrek, Michał, et al.
  Gepubliceerd in: (2016)